Announcing our collaboration with roche and aiims delhi for Cancer-related research
Pharma Solutions
What We Do Under Pharma Solutions Workstream
GGC provide multiple solutions for pharma industry, including but not limited to market research to introduce new healthcare products and technologies; market access to public reimbursement programs; data-driven insights to optimise market access, pricing, and stakeholder engagement for lasting success; end-to-end data management solutions for clinical trials to collect and manage patient data; health economic analysis; and real-word evidence transforming diverse real-world data into strategic intelligence.
List of Projects
For Roche, along with AIIMS Delhi, we will conduct a comprehensive assessment of the cost of diagnosis, treatment, and post-treatment care of breast and lung cancer patients in different tertiary healthcare settings as per the Standards of Care. Further, using the updated cost projections, we will calculate the additional funding needed to diagnose and treat the cancer-affected Pradhan Mantri Jan Arogya Yojana (PM-JAY) eligible population and recommend innovative financing strategies to cover this additional fund (Year 2025-26).
For Sathguru Management Consultants (SMC) and its client, Global Antibiotic Research and Development Partnership (GARDP), provided technical support in price sensitivity and COGS analysis for Cefiderocol in India. Towards this, we provided support in primary research with public health stakeholders[1]to understand the level of adoption of high-end antibiotics, the accessibility of the Ceftaz-avi drug (generics vs. originator) across public hospitals, procurement and pricing details, and the optimal price range suggested for the new drug cefiderocol.
For SMC and its client, GARDP, developed a pricing strategy and roadmap for expanding the adoption/coverage of a novel antibiotic in the Indian public health system.
For Alivecor India, we introduced the KardiaMobile 6Lin as a sub-channel partner in the public health system: an innovative 6 lead compact, portable, and easy-to-use USFDA-approved ECG device. Implementation sites are PHCs and CHCs in Odisha, a central government hospital in Delhi, and a district facility in Durg (Chhattisgarh).
[1] Clinicians engaged in critical care from public hospitals; Medical Superintendents of Public Medical Colleges; Procurement/administrative stakeholders from public hospitals; Procurement teams in Central / State Government schemes; and Payors.
